Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones

George Alexandrakis, Eduardo C Alfonso, Darlene Miller

Research output: Contribution to journalArticle

303 Citations (Scopus)

Abstract

Objective: To study the distribution, current trends, and patterns of resistance to antimicrobial agents of bacterial keratitis isolates in South Florida. Design: Retrospective, observational, case series. Participants: The microbiology records of all patients with bacterial keratitis seeking treatment at the Bascom Palmer Eye Institute from January 1, 1990 through December 31, 1998 were reviewed. Main Outcome Measures: In vitro laboratory minimum inhibitory concentration testing of the corneal isolates to the fluoroquinolones (ofloxacin and ciprofloxacin) and to the aminoglycosides (tobramycin and gentamicin) was performed using the Vitek (Automatic Microbial System Biomedeux Vitek, Inc., Hazelwood, Missouri) method. Results: During this 9-year period, 2920 consecutive corneal cultures were obtained, and a pathogen was recovered in 1468 cultures (50%). The number of corneal ulcers scraped, positive cultures, recovered bacterial isolates, and ratio of gram-positive to gram-negative isolates per year remained approximately equal throughout the study period. Staphylococcus aureus and Pseudomonas aeruginosa represented 19.4 % and 25.7%, respectively, of the total bacterial isolates during this period. However, we documented a gradual increase in the number of S. aureus keratitis isolates (29% of gram-positive organisms in 1990 versus 48% in 1998, P = 0.01) coupled with a decrease in the number of P. aeruginosa isolates (54% of gram-negative organisms in 1990 versus 46% in 1998). A decrease in the incidence of contact lens-associated keratitis and P. aeruginosa isolates in this group of patients was documented. Serratia marcescens and P. aeruginosa were most commonly isolated in contact lens-associated keratitis (18% each). There was increasing laboratory resistance of S. aureus keratitis isolates to the fluoroquinolones (11% in 1990 to 28% in 1998), but resistance patterns to the aminoglycosides remained unchanged. There was a three-fold increase in the percentage of resistant S. aureus isolates to fluoroquinolones between 1990 and 1994 and between 1995 and 1998. Both fluoroquinolones and aminoglycosides exhibited low in vitro effectiveness against P. aeruginosa throughout the study period. Conclusions: The increased recovery of S. aureus keratitis isolates and decreased laboratory effectiveness against fluoroquinolones to these pathogens present an important therapeutic challenge. (C) 2000 by the American Academy of Ophthalmology.

Original languageEnglish
Pages (from-to)1497-1502
Number of pages6
JournalOphthalmology
Volume107
Issue number8
DOIs
StatePublished - Nov 20 2000

Fingerprint

Keratitis
Fluoroquinolones
Pseudomonas aeruginosa
Staphylococcus aureus
Aminoglycosides
Contact Lenses
Corneal Ulcer
Serratia marcescens
Tobramycin
Ofloxacin
Microbial Sensitivity Tests
Ciprofloxacin
Anti-Infective Agents
Microbiology
Gentamicins
Outcome Assessment (Health Care)
Incidence
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. / Alexandrakis, George; Alfonso, Eduardo C; Miller, Darlene.

In: Ophthalmology, Vol. 107, No. 8, 20.11.2000, p. 1497-1502.

Research output: Contribution to journalArticle

@article{c798d5a85a2c4dde82eff532fd19eeca,
title = "Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones",
abstract = "Objective: To study the distribution, current trends, and patterns of resistance to antimicrobial agents of bacterial keratitis isolates in South Florida. Design: Retrospective, observational, case series. Participants: The microbiology records of all patients with bacterial keratitis seeking treatment at the Bascom Palmer Eye Institute from January 1, 1990 through December 31, 1998 were reviewed. Main Outcome Measures: In vitro laboratory minimum inhibitory concentration testing of the corneal isolates to the fluoroquinolones (ofloxacin and ciprofloxacin) and to the aminoglycosides (tobramycin and gentamicin) was performed using the Vitek (Automatic Microbial System Biomedeux Vitek, Inc., Hazelwood, Missouri) method. Results: During this 9-year period, 2920 consecutive corneal cultures were obtained, and a pathogen was recovered in 1468 cultures (50{\%}). The number of corneal ulcers scraped, positive cultures, recovered bacterial isolates, and ratio of gram-positive to gram-negative isolates per year remained approximately equal throughout the study period. Staphylococcus aureus and Pseudomonas aeruginosa represented 19.4 {\%} and 25.7{\%}, respectively, of the total bacterial isolates during this period. However, we documented a gradual increase in the number of S. aureus keratitis isolates (29{\%} of gram-positive organisms in 1990 versus 48{\%} in 1998, P = 0.01) coupled with a decrease in the number of P. aeruginosa isolates (54{\%} of gram-negative organisms in 1990 versus 46{\%} in 1998). A decrease in the incidence of contact lens-associated keratitis and P. aeruginosa isolates in this group of patients was documented. Serratia marcescens and P. aeruginosa were most commonly isolated in contact lens-associated keratitis (18{\%} each). There was increasing laboratory resistance of S. aureus keratitis isolates to the fluoroquinolones (11{\%} in 1990 to 28{\%} in 1998), but resistance patterns to the aminoglycosides remained unchanged. There was a three-fold increase in the percentage of resistant S. aureus isolates to fluoroquinolones between 1990 and 1994 and between 1995 and 1998. Both fluoroquinolones and aminoglycosides exhibited low in vitro effectiveness against P. aeruginosa throughout the study period. Conclusions: The increased recovery of S. aureus keratitis isolates and decreased laboratory effectiveness against fluoroquinolones to these pathogens present an important therapeutic challenge. (C) 2000 by the American Academy of Ophthalmology.",
author = "George Alexandrakis and Alfonso, {Eduardo C} and Darlene Miller",
year = "2000",
month = "11",
day = "20",
doi = "10.1016/S0161-6420(00)00179-2",
language = "English",
volume = "107",
pages = "1497--1502",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones

AU - Alexandrakis, George

AU - Alfonso, Eduardo C

AU - Miller, Darlene

PY - 2000/11/20

Y1 - 2000/11/20

N2 - Objective: To study the distribution, current trends, and patterns of resistance to antimicrobial agents of bacterial keratitis isolates in South Florida. Design: Retrospective, observational, case series. Participants: The microbiology records of all patients with bacterial keratitis seeking treatment at the Bascom Palmer Eye Institute from January 1, 1990 through December 31, 1998 were reviewed. Main Outcome Measures: In vitro laboratory minimum inhibitory concentration testing of the corneal isolates to the fluoroquinolones (ofloxacin and ciprofloxacin) and to the aminoglycosides (tobramycin and gentamicin) was performed using the Vitek (Automatic Microbial System Biomedeux Vitek, Inc., Hazelwood, Missouri) method. Results: During this 9-year period, 2920 consecutive corneal cultures were obtained, and a pathogen was recovered in 1468 cultures (50%). The number of corneal ulcers scraped, positive cultures, recovered bacterial isolates, and ratio of gram-positive to gram-negative isolates per year remained approximately equal throughout the study period. Staphylococcus aureus and Pseudomonas aeruginosa represented 19.4 % and 25.7%, respectively, of the total bacterial isolates during this period. However, we documented a gradual increase in the number of S. aureus keratitis isolates (29% of gram-positive organisms in 1990 versus 48% in 1998, P = 0.01) coupled with a decrease in the number of P. aeruginosa isolates (54% of gram-negative organisms in 1990 versus 46% in 1998). A decrease in the incidence of contact lens-associated keratitis and P. aeruginosa isolates in this group of patients was documented. Serratia marcescens and P. aeruginosa were most commonly isolated in contact lens-associated keratitis (18% each). There was increasing laboratory resistance of S. aureus keratitis isolates to the fluoroquinolones (11% in 1990 to 28% in 1998), but resistance patterns to the aminoglycosides remained unchanged. There was a three-fold increase in the percentage of resistant S. aureus isolates to fluoroquinolones between 1990 and 1994 and between 1995 and 1998. Both fluoroquinolones and aminoglycosides exhibited low in vitro effectiveness against P. aeruginosa throughout the study period. Conclusions: The increased recovery of S. aureus keratitis isolates and decreased laboratory effectiveness against fluoroquinolones to these pathogens present an important therapeutic challenge. (C) 2000 by the American Academy of Ophthalmology.

AB - Objective: To study the distribution, current trends, and patterns of resistance to antimicrobial agents of bacterial keratitis isolates in South Florida. Design: Retrospective, observational, case series. Participants: The microbiology records of all patients with bacterial keratitis seeking treatment at the Bascom Palmer Eye Institute from January 1, 1990 through December 31, 1998 were reviewed. Main Outcome Measures: In vitro laboratory minimum inhibitory concentration testing of the corneal isolates to the fluoroquinolones (ofloxacin and ciprofloxacin) and to the aminoglycosides (tobramycin and gentamicin) was performed using the Vitek (Automatic Microbial System Biomedeux Vitek, Inc., Hazelwood, Missouri) method. Results: During this 9-year period, 2920 consecutive corneal cultures were obtained, and a pathogen was recovered in 1468 cultures (50%). The number of corneal ulcers scraped, positive cultures, recovered bacterial isolates, and ratio of gram-positive to gram-negative isolates per year remained approximately equal throughout the study period. Staphylococcus aureus and Pseudomonas aeruginosa represented 19.4 % and 25.7%, respectively, of the total bacterial isolates during this period. However, we documented a gradual increase in the number of S. aureus keratitis isolates (29% of gram-positive organisms in 1990 versus 48% in 1998, P = 0.01) coupled with a decrease in the number of P. aeruginosa isolates (54% of gram-negative organisms in 1990 versus 46% in 1998). A decrease in the incidence of contact lens-associated keratitis and P. aeruginosa isolates in this group of patients was documented. Serratia marcescens and P. aeruginosa were most commonly isolated in contact lens-associated keratitis (18% each). There was increasing laboratory resistance of S. aureus keratitis isolates to the fluoroquinolones (11% in 1990 to 28% in 1998), but resistance patterns to the aminoglycosides remained unchanged. There was a three-fold increase in the percentage of resistant S. aureus isolates to fluoroquinolones between 1990 and 1994 and between 1995 and 1998. Both fluoroquinolones and aminoglycosides exhibited low in vitro effectiveness against P. aeruginosa throughout the study period. Conclusions: The increased recovery of S. aureus keratitis isolates and decreased laboratory effectiveness against fluoroquinolones to these pathogens present an important therapeutic challenge. (C) 2000 by the American Academy of Ophthalmology.

UR - http://www.scopus.com/inward/record.url?scp=0033777744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033777744&partnerID=8YFLogxK

U2 - 10.1016/S0161-6420(00)00179-2

DO - 10.1016/S0161-6420(00)00179-2

M3 - Article

C2 - 10919897

AN - SCOPUS:0033777744

VL - 107

SP - 1497

EP - 1502

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 8

ER -